AAAAAA

   
Results: 1-10 |
Results: 10
INCREASED PLATINUM-DNA DAMAGE TOLERANCE IS ASSOCIATED WITH CISPLATIN RESISTANCE AND CROSS-RESISTANCE TO VARIOUS CHEMOTHERAPEUTIC-AGENTS IN UNRELATED HUMAN OVARIAN-CANCER CELL-LINES
Authors: JOHNSON SW LAUB PB BEESLEY JS OZOLS RF HAMILTON TC
Citation: Sw. Johnson et al., INCREASED PLATINUM-DNA DAMAGE TOLERANCE IS ASSOCIATED WITH CISPLATIN RESISTANCE AND CROSS-RESISTANCE TO VARIOUS CHEMOTHERAPEUTIC-AGENTS IN UNRELATED HUMAN OVARIAN-CANCER CELL-LINES, Cancer research, 57(5), 1997, pp. 850-856
MICROSCOPIC BENIGN AND INVASIVE MALIGNANT NEOPLASMS AND A CANCER-PRONE PHENOTYPE IN PROPHYLACTIC OOPHORECTOMIES
Authors: SALAZAR H GODWIN AK DALY MB LAUB PB HOGAN WM ROSENBLUM N BOENTE MP LYNCH HT HAMILTON TC
Citation: H. Salazar et al., MICROSCOPIC BENIGN AND INVASIVE MALIGNANT NEOPLASMS AND A CANCER-PRONE PHENOTYPE IN PROPHYLACTIC OOPHORECTOMIES, Journal of the National Cancer Institute, 88(24), 1996, pp. 1810-1820
PHASE-I TRIAL OF THE THYMIDYLATE SYNTHASE INHIBITOR AG331 AS A 5-DAY CONTINUOUS-INFUSION
Authors: ODWYER PJ LAUB PB DEMARIA D QIAN MX REILLY D GIANTONIO B JOHNSTON AL WU EY BAUMAN L CLENDENINN NJ GALLO JM
Citation: Pj. Odwyer et al., PHASE-I TRIAL OF THE THYMIDYLATE SYNTHASE INHIBITOR AG331 AS A 5-DAY CONTINUOUS-INFUSION, Clinical cancer research, 2(10), 1996, pp. 1685-1692
NCOMP - A WINDOWS-BASED COMPUTER-PROGRAM FOR NONCOMPARTMENTAL ANALYSIS OF PHARMACOKINETIC DATA
Authors: LAUB PB GALLO JM
Citation: Pb. Laub et Jm. Gallo, NCOMP - A WINDOWS-BASED COMPUTER-PROGRAM FOR NONCOMPARTMENTAL ANALYSIS OF PHARMACOKINETIC DATA, Journal of pharmaceutical sciences, 85(4), 1996, pp. 393-395
NMR STRUCTURE OF AN INHIBITORY R2 C-TERMINAL PEPTIDE BOUND TO MOUSE RIBONUCLEOTIDE REDUCTASE R1 SUBUNIT
Authors: FISHER A LAUB PB COOPERMAN BS
Citation: A. Fisher et al., NMR STRUCTURE OF AN INHIBITORY R2 C-TERMINAL PEPTIDE BOUND TO MOUSE RIBONUCLEOTIDE REDUCTASE R1 SUBUNIT, Nature structural biology, 2(11), 1995, pp. 951-955
LOCALIZED SOLUTION STRUCTURE REFINEMENT OF AN F45W VARIANT OF UBIQUITIN USING STOCHASTIC BOUNDARY MOLECULAR-DYNAMICS AND NMR DISTANCE RESTRAINTS
Authors: LAUB PB KHORASANIZADEH S RODER H
Citation: Pb. Laub et al., LOCALIZED SOLUTION STRUCTURE REFINEMENT OF AN F45W VARIANT OF UBIQUITIN USING STOCHASTIC BOUNDARY MOLECULAR-DYNAMICS AND NMR DISTANCE RESTRAINTS, Protein science, 4(5), 1995, pp. 973-982
PROTEIN-FOLDING PATHWAYS AS REVEALED BY AMIDE PROTON-EXCHANGE MEASUREMENTS
Authors: RODER H SAUDER JM KHORASANIZADEH S LAUB PB PETERS ID
Citation: H. Roder et al., PROTEIN-FOLDING PATHWAYS AS REVEALED BY AMIDE PROTON-EXCHANGE MEASUREMENTS, Journal of cellular biochemistry, 1995, pp. 15-15
XPLCHK - AN EXTENSIBLE PROGRAM FOR CHECKING AND VALIDATING X-PLOR INPUT FILES
Authors: LAUB PB
Citation: Pb. Laub, XPLCHK - AN EXTENSIBLE PROGRAM FOR CHECKING AND VALIDATING X-PLOR INPUT FILES, Journal of applied crystallography, 28, 1995, pp. 632-634
TIME-DEPENDENT PHARMACODYNAMIC MODELS IN CANCER-CHEMOTHERAPY - POPULATION PHARMACODYNAMIC MODEL FOR GLUTATHIONE DEPLETION FOLLOWING MODULATION BY BUTHIONINE SULFOXIMINE (BSO) IN A PHASE-I TRIAL OF MELPHALAN AND BSO
Authors: GALLO JM BRENNAN J HAMILTON TC HALBHERR T LAUB PB OZOLS RF ODWYER PJ
Citation: Jm. Gallo et al., TIME-DEPENDENT PHARMACODYNAMIC MODELS IN CANCER-CHEMOTHERAPY - POPULATION PHARMACODYNAMIC MODEL FOR GLUTATHIONE DEPLETION FOLLOWING MODULATION BY BUTHIONINE SULFOXIMINE (BSO) IN A PHASE-I TRIAL OF MELPHALAN AND BSO, Cancer research, 55(20), 1995, pp. 4507-4511
A NONCOVALENT PEPTIDE COMPLEX AS A MODEL FOR AN EARLY FOLDING INTERMEDIATE OF CYTOCHROME-C
Authors: WU LC LAUB PB ELOVE GA CAREY J RODER H
Citation: Lc. Wu et al., A NONCOVALENT PEPTIDE COMPLEX AS A MODEL FOR AN EARLY FOLDING INTERMEDIATE OF CYTOCHROME-C, Biochemistry, 32(38), 1993, pp. 10271-10276
Risultati: 1-10 |